Displaying 1..1 of 1 -
per page
Order by
TAPESTRY PHARMACEUTICALS ANNOUNCES PLAN TO DISCONTINUE GENE EDITING OPERATIONS-Company to Focus on Lead Oncology Compounds-
More
Displaying 1..1 of 1 -
per page
Order by
Feb 2011 - 42 pages - $5,700
Apr 2011 - 26 pages - $500
Sep 2010 - 25 pages - $2,000
Oct 2011 - 27 pages - $500
Jul 2011 - 39 pages - $5,700
Apr 2011 - 78 pages - $3,500
Feb 2011 - 29 pages - $125
Dec 2010 - 28 pages - $125
May 2011 - 33 pages - $125
Apr 2011 - 75 pages - $3,800